LEADER 3D

As part of the Accelerating Rare disease Cures (ARC) Program, CDER’s Rare Diseases Team (RDT) inaugurated the Learning and Education to ADvance and Empower Rare Disease Drug Developers (LEADER 3D) initiative to better understand and address the unique challenges in...

ALTUVIIIO

STN: 125771Proper Name: antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtlTradename: ALTUVIIIOManufacturer: Bioverativ Therapeutics Inc., a Sanofi CompanyIndication:For use in adults and children with hemophilia A (congenital factor VIII deficiency)...